Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trialLars Klareskog, Marie Sanda, Désirée van der Heijde et al.|The Lancet|2004Cited by 1.8k
Tumor necrosis factor antagonist mechanisms of action: A comprehensive reviewDaniel E. Tracey, Paul P. Tak, Lars Klareskog et al.|Pharmacology & Therapeutics|2007Cited by 1.6k
A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullinationLars Klareskog, Lars Alfredsson, Patrik Stolt et al.|Arthritis & Rheumatism|2005Cited by 1.5k
<i>STAT4</i> and the Risk of Rheumatoid Arthritis and Systemic Lupus ErythematosusElaine F. Remmers, Peter K. Gregersen, Robert M. Plenge et al.|New England Journal of Medicine|2007Cited by 1.1k
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritisYun Liu, Andrew P. Feinberg, Lovisa E. Reinius et al.|Nature Biotechnology|2013Cited by 1k